|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical Portfolio Management: Strategies to Deliver Corporate Success
Datamonitor, Feb 2003, Pages: 207
Introduction
Senior pharmaceutical executives must manage a 'portfolio of portfolios' ensuring that the right investment decisions are made across their enterprise. The constant challenge in this environment is to determine which projects should receive investment. Portfolio management aims to meet this challenge and seeks to determine the optimal mix of projects within a portfolio.
Scope
Details the tools and processes needed for evaluating projects, strategically aligning portfolios, managing resource and maximizing portfolio value
Examines the technical and operational difficulties encountered during portfolio management and details strategies for overcoming these barriers
Examines current practice across more than 40 top-tier, mid-tier, specialty pharmaceutical and biotechnology companies from the US, Europe and Japan
Contributing companies include AstraZeneca, Aventis, Bayer, BMS, Chiron, Chugai, GSK, J&J, Lilly, Pfizer, Sankyo, Shionogi, Solvay, Takeda, TAP, Wyeth
Report Highlights
Benchmarks expected portfolio performance of the leading 40 pharmaceutical companies, forecasting total ethical sales and sales of portfolios across eight therapeutic areas between 2003 and 2008, as well as undertaking R&D productivity, identifying those companies and portfolios expected to out perform and under perform over this period.
Provides insight into the portfolio management systems and practices in place within pharmaceutical companies using detailed case studies based on interviews with portfolio management executives examining their experiences in designing and implementing portfolio management activities.
Analyzes the results of Datamonitor’s 2003 Portfolio Management Survey across more than 40 pharmaceutical companies which details portfolio management practices across the industry, executives opinion of practices within their own organizations and highlights deficiencies in current practice.
Reasons to Purchase
Improve buy-in within your organization at the project team level by understanding the objectives principles, and processes of portfolio management
Identify deficits in portfolio management practice and benchmark your organization against best practice across the pharmaceutical industry
Improve project evaluation by increasing your personnel’s knowledge of the strengths and weakness of financial tools and processes at their disposal
|
|
|
|
